Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
Harvard Business School
Merck
McKesson
Johnson and Johnson

Last Updated: October 1, 2022

Litigation Details for Silvergate Pharmaceuticals, Inc. v. Bionpharma Inc. (D. Del. 2018)


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Silvergate Pharmaceuticals, Inc. v. Bionpharma Inc. (D. Del. 2018)

Docket See Plans and Pricing Date Filed 2018-12-11
Court District Court, D. Delaware Date Terminated 2021-05-17
Cause 35:271 Patent Infringement Assigned To Leonard Philip Stark
Jury Demand None Referred To
Patents 10,039,745; 10,154,987; 10,183,004; 10,232,003; 10,279,012; 10,279,014; 6,168,016; 6,211,244; 6,316,460; 8,183,002; 8,222,015; 8,568,747; 9,194,011; 9,242,011; 9,297,019; 9,375,405; 9,669,008; 9,808,442
Link to Docket External link to docket
Small Molecule Drugs cited in Silvergate Pharmaceuticals, Inc. v. Bionpharma Inc.
The small molecule drugs covered by the patents cited in this case are See Plans and Pricing , See Plans and Pricing , See Plans and Pricing , See Plans and Pricing , and See Plans and Pricing .

Details for Silvergate Pharmaceuticals, Inc. v. Bionpharma Inc. (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
2020-12-13 and Counterclaims with Respect to U.S. Patent Nos. 9,669,008 and 9,808,442 filed by Silvergate Pharmaceuticals… 2018 17 May 2021 1:18-cv-01962 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2020-07-22 136 Notice of Service Byrn on Infringement of U.S. Patent Nos. 9,669,008; 9,808,442; 10,039,745; and 10,154,987; and (2) Opening…John D. Mahan, Jr., M.D. on Infringement of U.S. Patent 9,808,442 and 10,154,987 filed by Silvergate Pharmaceuticals… 2018 17 May 2021 1:18-cv-01962 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2020-10-19 145 Notice of Service Stephen Byrn on the Infringement of U.S. Patents 10,039,745 and 10,154,987 filed by Silvergate Pharmaceuticals… 2018 17 May 2021 1:18-cv-01962 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Colorcon
Dow
Merck
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.